Effect of Universal Health Coverage on the Availability of Medicines in Public Health Facilities in Kisumu County, in Kenya by Walukana, George et al.






Effect of Universal Health Coverage on the Availability of 
Medicines in Public Health Facilities in Kisumu County, in 
Kenya 
George Walukana1*, Shital Maru2, Peter Karimi2, Pierre Claver Kayumba1  
 
1EAC Regional Centre of Excellence for Vaccines, Immunization, and Health Supply Chain 
Management, College of Medicine and Health Sciences, University of Rwanda, Kigali, Rwanda 
2University of Nairobi, Nairobi, Kenya. 
 
*Corresponding Author: George Walukana. EAC Regional Centre of Excellence for Vaccines, 
Immunization, and Health Supply Chain Management, College of Medicine and Health Sciences, 
University of Rwanda, Kigali, Rwanda. Email:walukanagj@yahoo.com 
Abstract 
Background 
Stock outs of medicines and unaffordable cost are two major barriers of access to 
healthcare. Universal Health Coverage (UHC) seeks to ensure that all people have access 
to quality essential health services without suffering financial hardship.  
Objective 
The main objective of the study was to determine the effect and challenges of UHC 
program on the availability of medicines in public health facilities in Kisumu County.  
Methodology 
The study used a Pretest - posttest research design. The study was carried out in twenty-
nine health facilities that were selected using stratified random sampling. Data was 
collected using key informant interviews with a health worker in each facility. 
Participants also involved four hundred and forty-four patients selected from the chosen 
facilities using consecutive sampling.  Data from patients was collected using researcher 
administered questionnaires.  
Results 
The availability of medicines improved by 3.4% for 20 tracer medicines since the 
introduction of the pilot UHC in Kisumu County. This was also supported from the 
patient’s perspective (n= 444; 79.5%). However, in spite of this, health workers 
experienced challenges which included inadequate supply, delays and stock out of some 
medicines. Other challenges were overworking, shortage of qualified staff and 
inconsistent supplies.  
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Universal Health Coverage means that 
all people have access to essential 
quality health services without suffering 
financial hardship.[1] According to the 
World Bank and the World Health 
Organization, over 100 million 
individuals worldwide are driven into 
extreme poverty due to expenditure on 
health.[2] In September of 2015, world 
leaders meeting at the UN Summit in 
New York adopted the sustainable 
development agenda and its 17 
Sustainable Development Goals (SDGs) 
to build on the successes of the 
Millennium Development Goals and go 
even further in ending extreme 
poverty.[2] One  of the  goals is Good 
health and wellbeing.  
 
Health insurance coverage in Kenya is 
low at 19% although there has been a 
slight increase over the years.[3] 
According to the Kenya Household 
Health Expenditure and Utilization 
Survey Report 2013, only 17.1% 
Kenyans were covered by health 
insurance. [4] On the other hand, 6.21% 
of Households incurred catastrophic 
expenditure on health. That is, they 
spend more than 40% of their budget on 
non-food items to meet the cost of health 
care. This is an improvement over the 
previous measurements in 2007, with 
the health insurance coverage 
increasing from 10% and catastrophic 
expenditure falling from 11.4% 
respectively.[4] However, as the 
population grows, thousands of 
households continue to be driven to 
extreme poverty through spending on 
health.  
 
In December 2018, Kenya launched a 
pilot program for Universal Health 
Coverage to improve access to 
healthcare with an aim to achieve 100% 
coverage by the year 2022. [5] A system 
strengthening approach with input 
financing was used, where the 
government funds procurement of 
commodities through KEMSA, which 
then distributes to the health facilities 
where patients and clients can access 
services and the products without being 
charged user fees.[6] The success of this 
approach was hinged to a great degree 
on the performance of the entire supply 
chain system in place to deliver on the 
promise of UHC for all. This study 
investigated whether the roll out of UHC 
improved the availability of medicines in 
the public health facilities. The specific 
objectives of the study were: (1) to 
determine the availability of tracer 
medicines in public health facilities in 
Kisumu County before and after the roll 
out of Universal Health Coverage; (2) to 
determine the patient perception on 
availability of medicines in the health 
facilities in Kisumu; and (3) to 
investigate the supply chain challenges 
faced by public health facilities in 
Kisumu County after the roll out of UHC. 
The study addressed issues that touch 
on preparedness and performance of the 
supply chain system which in turn 
determine access to quality health care 















Research site and Research Design 
The study was conducted at twenty-nine 
public health facilities in Kisumu 
County which lies in the Lake Basin and 
western region of Kenya.  
The study used a pretest posttest study 
design. The exposure was UHC. The data 
of interest was collected before and after 
the introduction of UHC in Kisumu 
County. This design was appropriate 
because it enabled assessment of the 
effect of the program. This type of study 
is useful where the researcher has no 
control over the intervention due to 
political, practical or ethical barriers. As 
such, the study is designed to measure 
the performance before and after the 
intervention in the same study site and 
the changes are then attributed to the 
intervention.[7] 
Target and study population 
The study populations were health 
workers and patients from selected 
health facilities.  
Inclusion and exclusion criteria 
All the patients who were at least 18 
years of age attending the selected 
facilities on the day of the study and who 
were willing to participate were included. 
The study also included a health worker 
in the sampled facility involved in 
management of medicines and willing to 
participate. 
 
Sample size and sampling technique 
Twenty-nine health workers who were 
managing medicines at the health 
facilities were interviewed (one 
participant per facility). The sample size 
for the patients was 444. The sample 
size for the patients was determined 
through the use of Cochran’s formula for 
large populations with a 15% addition to 
cater for non-responses and incomplete 
questionnaires.[8] Two sampling 
techniques were used for the study. A 
stratified random sampling was used to 
select the health facilities where each 
category in the level of care was 
represented.  Within the selected health 
facilities, Consecutive sampling was 
used to select patients. This technique 
involves interviewing all eligible patients 
at a health facility until the sample 
target is met.[9]  
Data collection methods 
The data was collected using different 
methods. Researcher administered 
questionnaires were mainly used after 
pre-testing. The pilot testing was 
conducted at selected facilities not used 
for the actual study. Three types of data 
collection tools were used. These were 
the key informant guide and the tracer 
medicines questionnaire that were 
administered to health workers who are 
involved in management of medicines at 
the facility. The third one was the patient 
assessment questionnaire that was 
administered to patients as they exited 
the facilities.  
 
Data processing and analysis 
The quantitative data were collected 
through the mobile CommCare® 
application and imported into STATA® 
version 14 for analysis.  
Descriptive statistics were computed on 
proportions. Availability of adequate 
tracer medicines before and after the roll 
out of UHC was analyzed using means, 
proportions and difference in 
differences, which is a statistical 
approach that compares changes in 
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outcomes before and after an 
intervention.[10] Presentation of the 
data was in form of charts and tables. 
Qualitative data were also analyzed and 
reported using percentage and 
frequencies. These included challenges 
experienced by health workers and 




The approval to conduct the research 
was granted by the Kenyatta National 
Hospital-University of Nairobi Ethics 
and Research Committee (Ref KNH-
ERC/A/336) and all provisions were 
adhered to. Confidentiality and 
anonymity of the respondents was 
upheld throughout the research 
process. Approval was also obtained 
from the Department of Health, Kisumu 
County (Ref GN 133.VOLIII/834). The 
study only included consenting persons.  
 
Results  
Sociodemographic characteristics of 
the healthcare workers 
There was female predominance at 
55.2% and most of them were between 
25-34 years old (55.2%) as shown in 
table 1. All the interviewed healthcare 
workers had attained at least a 
minimum of diploma level of education 
and majority of them were nurses 
(51.7%). About a third (31.1%) had 
worked at the respective facilities for less 
than one year.  
Table 1. Socio-Demographic Characteristics of Health workers (n=29) 
Variables Frequency Percent 
Gender   
Male 13 44.8 
Female 16 55.2 
Age Category   
25-34 years 16 55.2 
35-44 years 9 31.0 
45-54 years 3 10.3 
55 years and over 1 3.5 
Education level   
Graduate 6 20.7 
Diploma 23 79.3 
Cadre of health worker   
Pharmacist 7 24.1 
Nurse 15 51.7 
Pharmaceutical technologist 4 13.8 
Other 3 10.4 
Duration worked in the facility   
Less than 1 year 9 31.1 
1-5 years 7 24.1 
6-10 years 5 17.2 
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11-15 years 4 13.8 
16+ years 4 13.8 
 
Sociodemographic characteristics of 
patients 
The Table 2 below shows the socio-
demographic characteristics of the 
patients involved in the study. One 
hundred and sixty-five (37.2%) patients 
were between 25 to 34 years old and 
about a half (205, 46.2%) had attained 
primary education. A majority (271,61%) 
of the participants walked to the health 
facilities to get services offered. A large 
proportion took less than 30 minutes to 
get to the facilities. 
Table 2. Socio-Demographic Characteristics of patients (n=444) 
Variables N % 
Age Category   
18-24 90 20.3 
25-34 165 37.2 
35-44 85 19.1 
45-54 46 10.4 
55+ 58 13.1 
Education level   
No education completed 30 6.8 
Primary 205 46.2 
Secondary 148 33.3 
Tertiary and above 60 13.5 
Don't know 1 0.2 
Mode of transport   
On foot 271 61.0 
Own bicycle 22 5.0 
Own car/Boat 4 0.9 
Paid transport 138 31.1 
Other 9 2.0 
Distance to health facility   
Less than 15 minutes 107 24.1 
15-30 minutes 189 42.6 
31 minutes-1hour 111 25.0 
More than 1 hour 36 8.1 














The availability of tracer medicines 
before and after roll out of UHC  
A list of 20 tracer medicines was used to 
determine their availability before and 
after the roll out of UHC in public health 
facilities in Kisumu County (Table 3). 
The was an increase in the availability of 
Amoxicillin 250mg capsules, Amoxicillin 
dispersible 250mg tablets, Cetirizine 
10mg tablets, ORS / Zinc tablets Co-
pack, Oxytocin Injection 5 IU/ml 
ampoule, Hydrocortisone 100mg 
injection and Enalapril 5mg tablets. 
However, a decrease in the availability of 
Paracetamol 500mg tablets, Co-
trimoxazole 480mg tablets, Albendazole 
400mg tablets, Metronidazole 
200mg/5ml Suspension, Gentamicin 
sulphate 80mg injection, 
Benzylpencillin 5MU injection, 
Adrenaline (epinephrine) Injection 
1mg/1ml, Chlorhexidine 4% cord care 
gel and Suxamethonium chloride Inj 
50mg/ml, 2ml amp was observed.  The 
availability of Tetracycline eye ointment 
1%, Insulin Biphasic 30/70, 
Clotrimazole 1% cream and Sodium 
Chloride IV 0.9% infusion showed no 
change. Overall, there was an average 
increase in the availability of   tracer 
medicines on average by 3.4% since the 
roll out of UHC. 
 
Table 3. Availability of adequate amount of tracer medicines 
Item description 
(Name/form/Strength) Pack size 








Amoxicillin 250mg capsules  1000s 23(79.3) 26(89.7) 10.4 
Amoxicillin 250mg tablets 
(Dispersible) 
 Pack of 20s  
10(34.5) 22(75.9) 41.4 
Paracetamol 500mg tablets  100's in Blisters  
26(89.7) 24(82.8) -6.9 
Co-Trimoxazole 480mg 
tablets  
100's in Blisters 
26(89.7) 23(79.3) -10.4 
Albendazole 400mg tablets  100's in Blisters 
25(86.2) 16(55.2) -31.0 




27(93.1) 25(86.2) -6.9 
Gentamicin sulphate 
40mg/ml injection, 2ml  
amp 
25(86.2) 22(75.9) -10.3 
Benzylpenicillin 5mu Inj   vial 26(89.7) 24(82.8) -6.9 
Adrenaline (epinephrine) Inj 
1mg/1ml 
amp 
27(93.1) 25(86.2) -6.9 
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Co-pack of 4 satchets of low 
osmolarity ORS (500ml 
formulation) + 10 tablets of 
dispersible zinc sulphate 
tablets 20mg 
Co-Pack 
25(86.2) 27(93.1) 6.9 
 Tetracycline eye ointment 
1%, 3.5g  
 tube  
27(93.1) 27(93.1) 0 
Clotrimazole cream 1% 20g tube 26(89.7) 26(89.7) 0 
Oxytocin Inj 5 IU/ml 
ampoule  
amp 




24(82.8) 25(86.2) 3.4 
Insulin biphasic 30/70 100 
IU/ml. 10ml  
vial 
7(24.1) 7(24.1) 0 
Enalapril 5mg tablets  100s 20(68.9) 23(79.3) 10.4 
Chlorhexidine 4% cordcare 
gel 
tube 
12(41.4) 9(31.0) -10.4 
Sodium chloride IV infusion 
0.9%, 500ml (Normal Saline) 
 bottle  
27(93.1) 27(93.1) 0 
Suxamethonium chloride Inj 
50mg/ml, 2ml amp  
amp 
4(13.8) 3(10.3) -3.5 
% Total 
      +3.4 
 
Patients’ perception on availability 
of medicines in Kisumu County 
A larger proportion (353, 79.5%) of 
patients were of the opinion that there 
was improved availability of medicines 
after UHC launch compared to the 
period before (Figure 1).  
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 Figure1. Perceptions of patients on availability of medicines 
A majority of the participants (309, 
69.6%) reported that they received all 
the drugs prescribed at the health 
facility while 129 (29.1%) had failed to 
get all the prescribed medicines. Six 
(1.4%) respondents did not give their 
perception.  
Most (56.6%) of the participants who 
didn’t get all the drugs revealed that they 
were going to buy drugs from 
community pharmacies while 22.5% 
indicated they would go back to the 
health facility and check later (Figure 2) 
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Supply chain challenges  
 
Eight main challenges were identified 
from the key informant interviews with 
health workers (Table 4). Inadequate 
supply of medicines (37.9 %) and delays 
experienced in the supply of medicines 
(24.1%) were the most cited challenges 
across the health facilities. 
Table4. Supply chain challenges 
  Health facility levels 
Factors 
Overall N 





Delays in supply of medicines 7(24.1) 1(14.3) 3(42.9) 3(42.9) 0(0.0) 
Inadequate supply of medicines 11(37.9) 5(45.5) 4(36.4) 2(18.2) 0(0.0) 
Inconsistent drug supply 2(6.9) 0(0.0) 2(100.0) 0(0.0) 0(0.0) 
Increased work load 2(6.9) 1(50.0) 1(50.0) 0(0.0) 0(0.0) 
Not all medicines needed 
supplied 1(3.5) 1(100.0) 0(0.0) 0(0.0) 0(0.0) 
Poor mode of delivery 1(3.5) 0(0.0) 1(100.0) 0(0.0) 0(0.0) 
Shortage of staff 2(6.9) 0(0.0) 1(50.0) 1(50.0) 0(0.0) 
Stock out of medicines 3(10.3) 1(33.3) 1(33.3) 0(0.0) 1(33.3) 
 
Discussion 
The findings from the study indicated 
that there was a general improvement 
(3.4%) in the availability of tracer 
essential medicines following the 
implementation of the UHC pilot. The 
information provided by the health care 
workers resonated with that of the 
patients during exit interviews. This 
observation concurred with that from 
Ghana where there was an increase in 
accessibility and utilization of medicines 
following implementation of their 
National Health Insurance Scheme.[11]  
The launch of the UHC improved the 
availability of medicines which was 
among the intended objectives. Under 
the model piloted in Kenya, the county 
governments are required to 
incrementally increase their allocation 
on health spending, therefore more 
resources than previously granted 
would be available for health services 
including provision of medicines.[6]  
The patients reported an improvement 
in the availability of medicines. This can 
have the positive effect of leading to 
greater uptake of health services in the 
roll out of UHC. The lack of medicines 
and exorbitant fees charged in public 
health facilities has been cited as one of 
the reasons for the disaffection by the 
public that resulted in some countries 
adopting some form of health insurance 
scheme for their populations. The key 
pillar of UHC is access to all that need 
health services without them suffering 
financial hardship. In a study on the 
effects of UHC, it is therefore imperative 
to get data from the patients accessing 
the health services at the facilities 
covered under the program.  
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Several studies conducted in Kenya have 
looked at the issue of Catastrophic 
Health Expenditures (CHE) for the poor. 
In a study by Buigut S, et al, between 
1.52 -28.38% of Kenyan households in 
informal settlements face this problem 
and cannot afford quality health 
care.[13] In another study by Kimani D, 
et al, the finding was that 11.7% of those 
who utilize health services face CHE 
while 4% were impoverished by out of 
pocket payments.[8] The findings from 
the two studies compare well with our 
findings of 18.6% of patients who cannot 
afford to buy the medicines from other 
sources. The implication of this is that a 
significant percentage of the population 
has no access to quality healthcare 
without the intervention of government 
and therefore would face a health 
catastrophe in the absence of a 
functioning UHC scheme. 
From the study the main challenges that 
were experienced by the health facilities 
in Kisumu after the roll out of the UHC 
pilot was inadequate supply of 
medicines. This is in line with the 
findings from patient exit interviews 
where 36.7% of the respondents said 
that although the medicines supply had 
improved after UHC, it was not 
adequate. This may result from the 
supplier (KEMSA) not delivering the 
required supplies or inaccurate 
forecasting of needs by the health 
facilities. The inability to supply all the 
medicines is consistent with findings of 
a study conducted in Embu County. [9] 
On the other hand, various reports from 
the MOH and supporting partners have 
identified lack of skills in forecasting and 
quantification as one of the main 
challenges faced by public health 
facilities.[16] 
Stock out of medicines was another 
identified challenge (10.3%) that affected 
all the levels with the exception of level 4 
hospitals. 4.3% of the patients 
interviewed did not receive any 
medicines at the facilities. This would be 
a hindrance to the attainment of UHC as 
it goes against offering quality health 
services and financial risk protection. A 
study of the systematic review of factors 
that affect the uptake of community 
based insurance in middle and low 
income countries, stockout of medicines 
is identified as one of the factors that 
hinder enrolment and attainment of 
UHC.[10] 
The health facilities also experienced 
delays in the supply of the medicines. 
This can be postulated to be the long 
lead times between making an order and 
receiving the supplies. Under the UHC 
pilot program, orders were made online 
by the health facilities and then 
approved at Sub County and County 
levels before they are submitted to 
KEMSA which required MOH approval 
before it processed the order and 
delivered to the health facility.[11] 
Shortage of qualified staff which 
includes nurses, pharmaceutical staff 
and clinicians was also identified as a 
challenge by the health workers which 
contributed to increased workload. 
According to Kenya Health Facility 
Assessment (KHFA), the service 
availability index score for 
infrastructure was quite high but the 
score for health workforce and service 
utilization were quite low.[12] Thus 
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shortage of staff may be a barrier to 
utilization of health services and 
therefore attainment of UHC.[13] This 
challenge is not unique to Kenya and 
Africa alone, and  a study in China 
documenting the challenges in the 
journey to UHC recommended  the use 
of health information technology such as 
mobile health and telemedicine to 
address the shortage of staff particularly 
in low income and remote areas.[14] 
Limitations of the study     
Due to resource constraints the study 
did not involve all the facilities in 
Kisumu County. The sample size may 
not allow the generalization of the 
findings to all the UHC implementing 
facilities in the country. Other factors 
both observed and non-observed may 
have an effect on the availability of 
medicines despite the roll out of UHC. 
The findings may therefore overestimate 
the effect of the intervention. 
Conclusion 
The rollout of UHC generally improved 
the availability of medicines in Kisumu 
County. Several challenges were 
encountered by the healthcare facilities 
which were not unique.  
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